IDF Premium courses

T2DM - Oral Agents Fact Checking

A customised set of modules addressing the ongoing needs of health professionals to manage type 2 diabetes using oral glucose-lowering agents.

uems

4 European CME credits (ECMEC)

4.6 (407)

Enrolled:

2231 Learners

Views:

126817

IDF Premium courses

Select language

About this course

This course will enhance core skills and competencies of health professionals to effectively manage type 2 diabetes using oral glucose-lowering agents.

Who is this course for?

All health professionals involved in diabetes management and care are eligible to take the course. In particular, health professionals who work in isolated, remote settings and lack access to latest evidence-based education resources.

Curriculum

Initial Self-Evaluation

Complete your initial self-evaluation before starting the course module.

Learning Objectives:

At the end of this module the learner will be able to:

  • Define the purpose and rationale for using oral glucose-lowering agents in type 2 diabetes mellitus (T2DM)
  • Describe the evidence for glucose-lowering therapy intensification to achieve tighter glycaemic control and improve long-term outcomes
  • Review classes of oral glucose-lowering agents and their comparative efficacy
  • Explain how to use newer and older oral glucose-lowering agents alone and in combination to achieve better glycaemic control
Learning Objectives:

At the end of this module the learner will be able to:

  • Compare effectiveness of oral glucose-lowering therapies to provide robust decreases in HbA1c
  • Compare and contrast inter- and intraclass risks of severe hypoglycaemia with oral glucose-lowering therapies
  • Describe potential benefits of oral glucose-lowering therapies to improve cardiovascular and renal outcomes and promote weight loss/neutrality
  • Discuss the cost-effectiveness of oral agents in the context of efficacy and safety in various settings
Learning Objectives:

At the end of this module the learner will be able to:

  • Discuss the risks and benefits of glucocentric and cardiocentric treatment approaches in type 2 diabetes mellitus (T2DM)
  • Review data that demonstrate the complementary nature of cardiocentric and glucocentric strategies to achieve optimal outcomes in T2DM
  • Adopt an individualised approach to T2DM management that balances potential benefits and harms in the context of patient preferences, goals and barriers to treatment
Learning Objectives:

At the end of this module the learner will be able to:

  • Apply current data and guidelines to various clinical scenarios
  • Identify patients who would benefit from, and then develop an individualised approach to, intensifying treatment

Complete your final self-evaluation to continue.

Please provide your feedback before continuing to print your certificate.

You can download and/or print your IDF Certificate.

coc courses

How it works

Certificate

Learners who complete all the course modules will receive an official IDF Certificate of Completion and four European CME credits.

Course Fees

The online course is supported by an educational grant from

This course is free of charge.

The course content was created by the International Centre for Professional Development in Health and Medicine (ICPDHM), along with a group of multidisciplinary international experts and further digitised by IDF for wider dissemination and access.

Learners Feedback

4.6

Average Rating

(407 ratings)
  • 63%
  • 34%
  • 2%
  • 0%
  • 0%
Course Details
Modules:

4

Course Duration:

5 hours

Approx. 3 weeks to complete

Language:

English

This online module is supported by an educational grant from

Course Features

Self-paced flexible learning

Case studies

Download course module

Certificate

European CME credits (ECMEC)

© 2022 - IDF - All Right Reserved | Privacy Policy 

Facebook
Twitter
Linkedin